AirSculpt Technologies, Inc.

AIRS Healthcare Medical Care Facilities

AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024.

Revenue
−8.71%
EPS
+33.3%
Free cash flow
−813.8%
Total debt
−90.4%

Quarter to September 2026, against a year earlier

0.55 0.89 −61.81%
Market cap
$103.8M
P/E
0.0×
Fwd P/E
−13.7×
Dividend yield
—
F-score
3/9
Altman Z
0.94
Beneish M
−3.34
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 1.80
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — 7 4 — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 85.47%

Capital & Financial Ratios $m

Size
Market Cap 103.82
Revenue ttm 147.68
Net income ttm (11.74)
Free cash flow ttm (2.54)
Net debt Q (9.72)
Valuation
P/E 0.00
Forward P/E (13.70) (negative: loss-making)
Price / sales 0.27
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.38
Financial health
Current ratio Q 0.85 (below 1: weak)
Debt / equity Q 0.05 (at or below 0.5: strong)
Interest coverage Q 0.00
Growth
Revenue growth Q −8.71% (below 0%: shrinking)
Operating income growth Q −103.69% (below 0%: shrinking)
EPS, this year −60.00% (below 0%: weak)
EPS, next year A +43.75% (at or above 15%: strong)
Revenue, next year A −0.54% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A +11.21%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 0.08%
10-year low 10-year high
P/B against its own 10 years 0.08%
10-year low 10-year high
EV/Sales against its own 10 years 0.08%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 10 8 8 15
Receivables 2 3 1 2
Inventory — — — —
Other — — — —
16 17 15 23
2023 2024 2025 Q'26
Payables 4 6 5 6
ST’ Debt 2 4 5 5
Other — — — —
20 29 28 27

Compound Annual Growth %

10y 5y 3y
Sales — 19.32% (3.47%)
Cash Flow — (26.01%) (49.78%)
Earnings — 0.00% 0.00%
Book Value — (6.64%) 7.42%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (0.03) (0.02) (0.10) — —
’25 (0.05) (0.01) (0.15) 0.02 (0.19)
’24 0.10 (0.06) (0.10) (0.09) (0.14)
’23 0.00 0.03 (0.03) (0.08) (0.08)
’22 (0.01) 0.01 (0.13) (0.13) (0.26)
’21 — — — — (0.01)
’20 — — — — 0.14
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 39 43 32 — —
’25 39 44 35 33 152
’24 48 51 43 39 180
’23 46 56 47 48 196
’22 40 50 39 41 169
’21 26 35 35 38 133
’20 — — 18 23 63
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 5 (1) (3) — —
’25 1 5 0 (3) 3
’24 3 3 2 3 11
’23 6 12 1 5 24
’22 7 10 0 7 24
’21 9 15 9 (6) 27
’20 — — — 14 14
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 5 (1) (4) — —
’25 (1) 5 0 (3) 1
’24 2 (1) (3) (1) (3)
’23 2 10 (1) 3 14
’22 3 9 (4) 4 12
’21 8 13 7 (8) 20
’20 — — — 10 10
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — 41 63 133 169 196 180 152 148 +24.3% 151 155 161 +1.9%
Gross margin, % — — — 62.44 62.61 66.59 62.81 62.34 60.55 59.37 0.00 (3.1) pt
EBT — — — (2) 8 11 (11) 3 (8) (18) (18) +41.3%
EBT margin, % — — — (5.36) 12.07 8.16 (6.69) 1.65 (4.34) (11.62) 0.00 (6.3) pt
Net income — 0 — (2) 8 11 (15) (4) (8) (12) (12) n/m
Per share, $
Per share, $ Revenue — — — 0.74 1.13 2.40 3.03 3.45 3.13 2.51 2.04 +22.6%
Earnings — — — (0.04) 0.14 (0.01) (0.26) (0.08) (0.14) (0.19) (0.13) +29.7%
Cash flow — — — 0.09 0.25 0.48 0.44 0.42 0.20 0.05 (0.03) (8.8%)
Capex — — — (0.08) (0.07) (0.13) (0.23) (0.17) (0.24) (0.04) (0.01) (10.9%)
Free cash flow — — — 0.01 0.18 0.35 0.21 0.25 (0.05) 0.01 (0.03) +4.0%
Book value — — — 2.16 2.22 1.50 1.27 1.48 1.36 1.45 1.46 (6.4%)
Shares, m — — — 56 56 56 56 57 58 60 68 +1.4%
Valuation, ×
Valuation, × P/E — — — 33.81 33.81 0.00 0.00 0.00 0.00 0.00 0.00 9.7
P/S — — — 7.45 7.45 7.17 1.22 2.08 1.66 0.79 0.27 4.0
P/B — — — 0.00 0.00 11.45 2.92 4.86 3.83 1.36 0.38 3.5
EV/Sales — — — 8.31 8.31 7.60 1.66 2.40 2.03 1.10 0.43 4.5
EV/FCF — — — 26.02 26.02 51.94 24.34 33.45 (137.70) 241.75 (24.95) 38.0
Cash, $m
Cash, $m Operating cash flow — — — 5 14 27 24 24 11 3 (2) (7.5%)
Capex — — — (4) (4) (7) (13) (10) (14) (2) (1) (9.7%)
Free cash flow — — — 0 10 20 12 14 (3) 1 (3) +5.6%
Balance, $m
Balance, $m Working capital — — — (2) 2 13 (6) (4) (12) (12) (4) +38.5%
Net debt — — — 28 22 57 74 61 66 48 (10) +9.5%
Shareholders’ equity — — — 120 124 84 71 84 78 88 106 (5.1%)
Returns, %
Returns, % ROA — — — (2.58) 4.32 (0.21) (7.32) (2.09) (3.85) (5.83) 0.00 (3.2) pt
ROIC — — — 0.28 4.30 7.00 (1.96) 4.18 (0.68) (5.34) 0.00 (5.6) pt
ROE — — — (1.81) 6.21 (0.38) (19.03) (5.48) (9.89) (14.07) 0.00 (12.3) pt
People
People Employees — — — — 260 268 302 381 422 363 — +6.9%
Revenue/emp, $m — — — 0.00 0.24 0.50 0.56 0.51 0.43 0.42 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 6 Nov 2026

AirSculpt Technologies, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
AUNA Auna S.A. $339.7M 66.7× 6.1× +20.51% (above 0%: growing) −61.29% (below 0%: shrinking) +121.08% (above 0%: growing) 35.72% 13.09% Compare
CYH Community Health Systems, Inc. $321.5M 4.2× — (loss-making) −10.69% (below 0%: shrinking) n/m +857.14% (above 0%: growing) 85.24% 5.30% Compare
JYNT The Joint Corp. $104.2M 25.5× 20.1× +14.41% (above 0%: growing) +400.00% (above 0%: growing) +432.31% (above 0%: growing) 83.68% (2.43%) Compare
AIRS AirSculpt Technologies, Inc. $103.8M — (loss-making) — (loss-making) −8.71% (below 0%: shrinking) n/m −813.83% (below 0%: shrinking) 0.00% 0.00%
PARK Park Dental Partners, Inc. $95.8M — (loss-making) — +12.15% (above 0%: growing) −65.84% (below 0%: shrinking) −34.78% (below 0%: shrinking) 14.37% 1.90% Compare
BMGL Basel Medical Group Ltd $70.5M — — — — — — — Compare
CCEL Cryo-Cell International Inc. $39.9M — (loss-making) 65.1× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
BTMD biote Corp. $37.4M 6.6× — (loss-making) −9.48% (below 0%: shrinking) n/m −174.16% (below 0%: shrinking) 65.38% (7.93%) Compare
PIII P3 Health Partners Inc. $28.1M — (loss-making) — +8.60% (above 0%: growing) n/m −272.24% (below 0%: shrinking) 22.26% 10.67% Compare
Median of peers $83.1M 16.1× 20.1× +8.60% +8.25% −34.78% 65.38% 5.30%

All 51 Medical Care Facilities stocks →

AirSculpt Technologies, Inc. (AIRS) Latest News

17 Aug

Impact 3 · · The Motley Fool transcript

8 May

17 Nov

Impact 3 · · GlobeNewswireMT NewswiresMotley FoolGuruFocus.comGuruFocus.com

7 Nov

Impact 4 · · GlobeNewswire earnings
Impact 3 · · MT Newswires
stockrow.com/AIRS · Data as of Nov 6, 2026 · For information only; not investment advice. · © 2026 stockrow.com